课题基金 / 基金详情

项目摘要

项目成果

SAN MING WANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our proposal addresses the PQD3 in the RFA-CA-12-022: "What underlying causal events - e.g., genetic, epigenetic, biologic, behavioral, or environmental - allow certain individuals to survive beyond the expected limits of otherwise highly lethal cancers?" BRCA1 mutation is one of the best-known genetic causes for breast cancer. In BRCA1+ families, up to 80% of the family members who inherited BRCA1 mutation will develop breast cancer by age of 70, whereas 20% of the family members who also inherited BRCA1 mutation (BRCA1+ carrier) are breast cancer-resistance in that they will never develop breast cancer in their lifetime. In this proposal, we plan to study the genetic basis of breast cancer-resistance. We plan to use exome sequencing method to compare the entire genes between the breast cancer-affected and breast cancer- unaffected pairs from the same BRCA1+ families to identify the genes mutated differently between the two types of family members and to determine their functional relevance to breast cancer. Our proposal directly addresses the PQD3 by identifying the genes that protect the BRCA1+ individuals from breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQD3) Genetic Basis of Breast Cancer Resistance in BRCA1+ Carrier
Identification of novel genes in human genome
  • 批准号:
    6685335
  • 项目类别:
  • 资助金额:
    $9.46万
  • 财政年份:
    2003
  • 负责人:
    SAN MING WANG
  • 依托单位:
Identification of novel genes in human genome
Identification of novel genes in human genome
海外基金